Thymic neuroendocrine carcinoma
Clinical trials for Thymic neuroendocrine carcinoma explained in plain language.
Never miss a new study
Get alerted when new Thymic neuroendocrine carcinoma trials appear
Sign up with your email to follow new studies for Thymic neuroendocrine carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive drug targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, 225Ac-ETN029, in 116 adults with advanced DLL3-positive cancers like small cell lung cancer or neuroendocrine tumors. The main goal is to check safety and find the right dose, while also seeing if the drug can shrink tumors. Pa…
Matched conditions: THYMIC NEUROENDOCRINE CARCINOMA
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Custom mRNA vaccine takes on rare endocrine cancers
Disease control Recruiting nowThis early study tests a personalized mRNA vaccine (mRNA-0523-L001) for people with advanced endocrine tumors like adrenal cancer, medullary thyroid cancer, and pancreatic neuroendocrine tumors who have no standard treatment left. The vaccine is made to target unique mutations in…
Matched conditions: THYMIC NEUROENDOCRINE CARCINOMA
Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC